These guidelines are a statement of consensus of the authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient's care or treatment. The National Comprehensive Cancer Network makes no representation or warranties of any kind regarding their content, use, or application and disclaims any responsibility for their applications or use in any way.
These guidelines are copyrighted by the National Comprehensive Cancer Network. All rights reserved. These guidelines and the illustrations herein may not be reproduced in any form without the express written permission of the NCCN © 2010.
At the beginning of each NCCN guidelines panel meeting, panel members disclosed any financial support they have received from industry. Through 2008, this information was published in an aggregate statement in JNCCN and online. Furthering NCCN's commitment to public transparency, this disclosure process has now been expanded by listing all potential conflicts of interest respective to each individual expert panel member.
Individual disclosures for the NCCN Distress Management Guidelines Panel members can be found on page 485. (The most recent version of these guidelines and accompanying disclosures, including levels of compensation, are available on the NCCN Web site at www.NCCN.org.)
These guidelines are also available on the Internet. For the latest update, please visit www.NCCN.org.
Kadan-Lottick NS, Vanderwerker LC, Block SD et al.. Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study. Cancer 2005;104:2872–2881.
Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84:1011–1015.
Zabora JR. Screening procedures for psychosocial distress. In: Holland JC, Breitbart W, Jacobsen PB, et al., eds. Psycho-Oncology. New York: Oxford University Press; 1998:653–661.
Institute of Medicine. Cancer care for the whole patient: meeting psychosocial health needs. Washington, D.C.: National Academies Press; 2007.
Holland JC. American Cancer Society Award lecture. Psychological care of patients: psycho-oncology's contribution. J Clin Oncol 2003;21(23 Suppl):253s–265s.
Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin 2008;58:214–230.
Carlson LE, Bultz BD. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology 2004;13:837–849; discussion 850–836.
Carr D, Goudas L, Lawrence D et al.. Management of cancer symptoms: pain, depression, and fatigue. Evidence report/technology assessment No. 61 (prepared by the New England Medical Center Evidence-based Practice Center under contract No 290-97-0019). AHRQ Publication No. 02-E032. Rockville (MD): Agency for Healthcare Research and Quality; 2002.
- Search Google Scholar
- Export Citation
. Management of cancer symptoms: pain, depression, and fatigue. Carr D Goudas L Lawrence D Evidence report/technology assessment No. 61 (prepared by the New England Medical Center Evidence-based Practice Center under contract No 290-97-0019). AHRQ Publication No. 02-E032. Rockville (MD): Agency for Healthcare Research and Quality; 2002.
Zabora J, BrintzenhofeSzoc K, Curbow B et al.. The prevalence of psychological distress by cancer site. Psychooncology 2001;10:19–28.
Hegel MT, Moore CP, Collins ED et al.. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 2006;107:2924–2931.
Anderson-Hanley C, Sherman ML, Riggs R et al.. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 2003;9:967–982.
Stewart A, Bielajew C, Collins B et al.. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006;20:76–89.
Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007;25:2455–2463.
Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003;21:602–606.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101–2107.
Kroenke CH, Kubzansky LD, Schernhammer ES et al.. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 2006;24:1105–1111.
Moorey S, Greer S, Watson M, Baruch J. Adjuvant psychological therapy for patients with cancer: outcome at one year. Psychooncology 1994;3:39–46.
Gielissen MF, Verhagen CA, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer 2007;97:612–618.
Kohli S, Fisher SG, Tra Y et al.. The effect of modafinil on cognitive function in breast cancer survivors. Cancer 2009;115:2605–2616.
Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16:2522–2527.
Shaw EG, Rosdhal R, D'Agostino RB Jr et al.. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006;24:1415–1420.
Ferguson RJ, Ahles TA, Saykin AJ et al.. Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 2007;16:772–777.
Vardy J, Wefel JS, Ahles T et al.. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008;19:623–629.
Goodwin PJ, Leszcz M, Ennis M et al.. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001;345:1719–1726.
Kissane DW, Grabsch B, Clarke DM et al.. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 2007;16:277–286.
Kissane DW, Bloch S, Smith GC et al.. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psychooncology 2003;12:532–546.
Kissane DW, McKenzie M, Bloch S et al.. Family focused grief therapy: a randomized, controlled trial in palliative care and bereavement. Am J Psychiatry 2006;163:1208–1218.
Manne SL, Ostroff JS, Norton TR et al.. Cancer-related relationship communication in couples coping with early stage breast cancer. Psychooncology 2006;15:234–247.
Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007;25:4670–4681.
Zabora J, BrintzenhofeSzoc K, Jacobsen P et al.. A new psychosocial screening instrument for use with cancer patients. Psychosomatics 2001;42:241–246.
Mitchell AJ, Kaar S, Coggan C, Herdman J. Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists. Psychooncology 2008;17:226–236.
Fitchett G, Handzo G. Spiritual assessment, screening, and intervention. In: Holland JC, ed. Psycho-Oncology. New York: Oxford University Press; 1998:790–808.
Holland JC, Greenberg DB, Hughes MK, eds. Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management Oncology. Charlottlesville (VA): IPOS Press; 2006.
Holland JC, Andersen B, Breitbart WS et al.. NCCN clinical practice guidelines in oncology: distress management. version 1, 2010. Available at: http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf. Accessed February 19, 2010.
Lee SJ, Schover LR, Partridge AH et al.. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917–2931.
Akizuki N, Akechi T, Nakanishi T et al.. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 2003;97:2605–2613.
Dabrowski M, Boucher K, Ward JH et al.. Clinical experience with the NCCN distress thermometer in breast cancer patients. J Natl Compr Canc Netw 2007;5:104–111.
Jacobsen PB, Donovan KA, Trask PC et al.. Screening for psychologic distress in ambulatory cancer patients. Cancer 2005;103:1494–1502.
Patrick-Miller LJ, Broccoli TL, Much JK, Levine E. Validation of the Distress Thermometer: a single item screen to detect clinically significant psychological distress in ambulatory oncology patients [abstract]. J Clin Oncol 2004;22(Suppl 1):Abstact 6024.
Roth AJ, Kornblith AB, Batel-Copel L et al.. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998;82:1904–1908.
Zwahlen D, Hagenbuch N, Carley MI et al.. Screening cancer patients' families with the distress thermometer (DT): a validation study. Psychooncology 2008;17:959–966.
Hoffman BM, Zevon MA, D'Arrigo MC, Cecchini TB. Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology 2004;13:792–799.
Graves KD, Arnold SM, Love CL et al.. Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer 2007;55:215–224.
Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer 2008;113:870–878.
Ransom S, Jacobsen PB, Booth-Jones M. Validation of the Distress Thermometer with bone marrow transplant patients. Psychooncology 2006;15:604–612.
Trask PC, Paterson A, Riba M et al.. Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant 2002;29:917–925.
Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA 1995;274:1874–1880.
Breitbart W. Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support Care Cancer 1995;3:45–60.
Neuss MN, Desch CE, McNiff KK et al.. A process for measuring the quality of cancer care: the quality oncology practice initiative. J Clin Oncol 2005;23:6233–6239.
Jacobson JO, Neuss MN, McNiff KK et al.. Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative. J Clin Oncol 2008;26:1893–1898.
Blayney DW, McNiff K, Hanauer D et al.. Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer Center. J Clin Oncol 2009;27:3802–3807.
Ryan H, Schofield P, Cockburn J et al.. How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care (Engl) 2005;14:7–15.
Lawlor PG, Gagnon B, Mancini IL et al.. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000;160:786–794.
Stark D, Kiely M, Smith A et al.. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002;20:3137–3148.
Jacobsen PB, Donovan KA, Swaine ZN, Watson IS. Management of anxiety and depression in adult cancer patients: toward an evidence-based approach. In: Chang AE, Ganz PA, Hayes DF, et al., eds. Oncology: An Evidence-Based Approach. New York: Springer-Verlag; 2006:1561–1588.
- Search Google Scholar
- Export Citation
. Jacobsen PB Donovan KA Swaine ZN Watson IS Management of anxiety and depression in adult cancer patients: toward an evidence-based approach. In: Chang AE, Ganz PA, Hayes DF, et al., eds.Oncology: An Evidence-Based Approach. New York: Springer-Verlag; 2006: 1561– 1588.
Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr 2004:32–39.
Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer 2006;94:372–390.
Wald TG, Kathol RG, Noyes R Jr et al.. Rapid relief of anxiety in cancer patients with both alprazolam and placebo. Psychosomatics 1993;34:324–332.
Fisch MJ, Loehrer PJ, Kristeller J et al.. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 2003;21:1937–1943.
Holland JC, Romano SJ, Heiligenstein JH et al.. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 1998;7:291–300.
Balboni TA, Vanderwerker LC, Block SD et al.. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol 2007;25:555–560.
Astrow AB, Wexler A, Texeira K et al.. Is failure to meet spiritual needs associated with cancer patients' perceptions of quality of care and their satisfaction with care? J Clin Oncol 2007;25:5753–5757.
Puchalski C, Ferrell B, Virani R et al.. Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference. J Palliat Med 2009;12:885–904.
Jacobsen PB, Ransom S. Implementation of NCCN distress management guidelines by member institutions. J Natl Compr Canc Netw 2007;5:99–103.
Kornblith AB, Dowell JM, Herndon JE II et al.. Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study. Cancer 2006;107:2706–2714.
Stuck AE, Egger M, Hammer A et al.. Home visits to prevent nursing home admission and functional decline in elderly people: systematic review and meta-regression analysis. JAMA 2002;287:1022–1028.
Holland JC, Bultz BD. The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw 2007;5:3–7.